Establishing A Resilient cGMP Chemical Supply Chain

Today’s biopharmaceutical innovators and contract development and manufacturing organizations (CDMOs) face no shortage of challenges in their current good manufacturing practices (cGMP) chemical supply chain operations. Materials can suddenly be in short supply, leaving manufacturers to compete for increasingly scarce, yet vital, materials.

There are many approaches to enhancing the resiliency of a supply chain and identifying inefficiencies and added costs in a biomanufacturing workflow. It’s important to arrive at a total cost of ownership (TCO), which only emerges from a holistic examination of your total workflow. Arriving at TCO can be made easier by applying Lean Six Sigma™ methods or another process framework to the totality of your supply chain. A chain is only as strong as its weakest link; that is why the entirety of your supply chain should be considered before building resilience into your workflow. Here are the most important considerations to make.